menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

DEM BioPharma

An immuno-oncology company that develops therapies targeting DEM and EM signals to activate the innate immune system for tumor elimination.

Dewpoint

Develops therapies targeting protein phase transitions in cells, using biomolecular condensate technology to advance drug discovery and treatment.

Dragonfly Therapeutics

Creates immune-based therapies designed to target and eliminate cancer cells.

Dren Bio

Developing powerful protein engineering technologies to deplete cells, protein aggregates and other disease-causing agents.

Eikon Therapeutics Inc-Logo

Eikon Therapeutics

Uses revolutionary technology to discover novel treatments for life-threatening diseases.

Electra Therapeutics

Biotech company developing antibody therapies targeting immune system dysfunction and cancer through signal regulatory protein technology.

Elembio-Logo

Element Biosciences

Genetic analysis tools for the research and diagnostic markets.

Elevian

Develops regenerative medicines and protein therapies to enhance recovery after stroke and aging-related conditions by stimulating tissue repair.

Elpis Biopharmaceuticals

Biotech company develops innovative cancer treatments using bispecific antibodies and CAR-T therapies to target solid and blood tumors.

Empirico

Biotech company uses genetic data and siRNA technology to develop targeted therapeutics for common diseases with unmet medical needs.

Empyrean Neuroscience

Biotech firm engineers fungi and plant genomes to develop therapeutic compounds targeting neurological and psychiatric disorders.

Enable Medicine

Biotech company leverages AI to analyze biological data and accelerate drug discovery through integrated cellular and spatial analysis.

Entos

Develops small-molecule therapeutics using AI-driven platform that combines physics-based algorithms with experimental testing

Enveda Biosciences

Biotech company uses AI to analyze natural compounds and discover new drugs, transforming plant-based molecules into potential medicines.

Epic Bio

Develops epigenetic engineering therapies to modulate gene expression without DNA modification, using compact CRISPR delivery systems.

Expansion Therapeutics

Biotech company develops oral medicines targeting RNA to treat neurological disorders using small molecule technology.

EXUMA Biotech

Develops gene vector delivery platforms to make cell and gene therapies more accessible, cost-effective, and safer for patients.

Faraday Pharmaceuticals

Develops treatments to prevent heart failure by reducing myocardial damage following acute STEMI.